학술논문

Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study
Document Type
Article
Source
In: Journal of the European Academy of Dermatology and Venereology. (Journal of the European Academy of Dermatology and Venereology, July 2021, 35(7):1562-1568)
Subject
Language
English
ISSN
14683083
09269959